Calithera Biosciences
Christopher Molineaux has a wealth of experience in the pharmaceutical industry, having held various senior positions at companies such as Calithera Biosciences, Proteolix, FibroGen, Praecis Pharmaceuticals, Merck, and Enzon Pharmaceuticals. With a background in pharmacology and protein structure, Christopher has also worked as an Assistant Professor at the Icahn School of Medicine at Mount Sinai. Christopher completed their Postdoctoral Fellowship in Pharmacology at the Uniformed Services University and obtained their degree from The Johns Hopkins University.
This person is not in any offices
Calithera Biosciences
Calithera is developing first-in-class small molecule drugs directed against tumor metabolism and tumor immunology targets to treat cancer.